SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2US'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_A_NCAA700_0 (EXOTOXIN A) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 7 | HIS C 862GLY C 863TYR C 896TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.52A | 1dmaA-4oqaC:5.4 | 1dmaA-4oqaC:17.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_B_NCAB700_0 (EXOTOXIN A) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 6 | HIS C 862GLY C 863TYR C 896ALA C 898TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.40A | 1dmaB-4oqaC:5.9 | 1dmaB-4oqaC:17.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAT_A_CLMA301_0 (XENOBIOTICACETYLTRANSFERASE) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 3 / 3 | GLY C 863TYR C 907SER C 904 | 2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A) | 0.66A | 2xatA-4oqaC:undetectable | 2xatA-4oqaC:16.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 12 | GLY C 871ILE C 895HIS C 862LEU C 920LEU C 999 | NoneNone2US C1101 (-3.7A)NoneNone | 1.05A | 3cs8A-4oqaC:undetectable | 3cs8A-4oqaC:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_A_NCAA1163_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863ALA C 898LYS C 903SER C 904GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.2A) | 1.38A | 3u9hA-4oqaC:18.6 | 3u9hA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_A_NCAA1163_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863ALA C 898SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.88A | 3u9hA-4oqaC:18.6 | 3u9hA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_A_NCAA1163_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898LYS C 903SER C 904 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A) | 0.94A | 3u9hA-4oqaC:18.6 | 3u9hA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_A_NCAA1163_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898SER C 904TYR C 907 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.52A | 3u9hA-4oqaC:18.6 | 3u9hA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_B_NCAB1164_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863ALA C 898SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.84A | 3u9hB-4oqaC:18.6 | 3u9hB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_B_NCAB1164_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 8 | HIS C 862GLY C 863LYS C 903SER C 904GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.2A) | 1.44A | 3u9hB-4oqaC:18.6 | 3u9hB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_B_NCAB1164_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898SER C 904TYR C 907 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.55A | 3u9hB-4oqaC:18.6 | 3u9hB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U9H_B_NCAB1164_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 8 | HIS C 862GLY C 863TYR C 896LYS C 903SER C 904 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 ( 4.8A)2US C1101 (-3.4A) | 1.01A | 3u9hB-4oqaC:18.6 | 3u9hB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A99_D_MIYD392_1 (TETX2 PROTEIN) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 4 / 5 | HIS C 826SER C 902SER C 904VAL C 901 | NoneNone2US C1101 (-3.4A)None | 1.47A | 4a99D-4oqaC:undetectable | 4a99D-4oqaC:25.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 6 | HIS C 862GLY C 863TYR C 896TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.53A | 4ae1A-4oqaC:6.3 | 4ae1A-4oqaC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 5 / 5 | HIS C 862GLY C 863TYR C 896TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.50A | 4ae1B-4oqaC:4.8 | 4ae1B-4oqaC:23.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BJC_A_RPBA2162_1 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863ALA C 898LYS C 903SER C 904GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.2A) | 1.36A | 4bjcA-4oqaC:18.2 | 4bjcA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BJC_A_RPBA2162_1 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863ALA C 898SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.81A | 4bjcA-4oqaC:18.2 | 4bjcA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BJC_A_RPBA2162_1 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898LYS C 903SER C 904 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A) | 0.93A | 4bjcA-4oqaC:18.2 | 4bjcA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BJC_A_RPBA2162_1 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898SER C 904TYR C 907 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.44A | 4bjcA-4oqaC:18.2 | 4bjcA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_A_NCAA1201_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 7 / 7 | HIS C 862GLY C 863TYR C 896ALA C 898SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.66A | 4hyfA-4oqaC:19.7 | 4hyfA-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_B_NCAB1201_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 7 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898LYS C 903SER C 904GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.2A) | 0.89A | 4hyfB-4oqaC:19.8 | 4hyfB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_B_NCAB1201_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 7 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.66A | 4hyfB-4oqaC:19.8 | 4hyfB-4oqaC:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_C_NCAC1201_0 (TANKYRASE-2) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 8 / 8 | HIS C 862GLY C 863TYR C 896ALA C 898LYS C 903SER C 904TYR C 907GLU C 988 | 2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.62A | 4hyfC-4oqaC:19.8 | 4hyfC-4oqaC:18.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 10 / 11 | GLN C 759HIS C 862GLY C 863TYR C 889TYR C 896ALA C 898LYS C 903SER C 904TYR C 907GLU C 988 | None2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.57A | 4rv6A-4oqaC:47.9 | 4rv6A-4oqaC:79.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 11 | GLU C 763HIS C 862GLY C 863ALA C 898SER C 904TYR C 907 | None2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.86A | 4rv6A-4oqaC:47.9 | 4rv6A-4oqaC:79.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 10 / 11 | GLN C 759HIS C 862GLY C 863TYR C 889TYR C 896ALA C 898LYS C 903SER C 904TYR C 907GLU C 988 | None2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.3A)2US C1101 (-4.2A)2US C1101 (-3.5A)2US C1101 ( 4.8A)2US C1101 (-3.4A)2US C1101 (-3.5A)2US C1101 (-3.2A) | 0.57A | 4rv6B-4oqaC:48.1 | 4rv6B-4oqaC:79.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 11 | GLU C 763HIS C 862GLY C 863ALA C 898SER C 904TYR C 907 | None2US C1101 (-3.7A)2US C1101 (-3.3A)2US C1101 (-3.5A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.87A | 4rv6B-4oqaC:48.1 | 4rv6B-4oqaC:79.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 6 / 9 | ASP C 770SER C 864ASN C 868ILE C 872SER C 904TYR C 907 | NoneNoneNoneNone2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.86A | 5ha9B-4oqaC:46.1 | 5ha9B-4oqaC:86.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homosapiens) | 7 / 9 | HIS C 862SER C 864ASN C 868ILE C 872TYR C 896SER C 904TYR C 907 | 2US C1101 (-3.7A)NoneNoneNone2US C1101 (-4.2A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.47A | 5ha9B-4oqaC:46.1 | 5ha9B-4oqaC:86.03 |